Every month our premium InvestingPro subscribers get exclusive access to our Pro Picks: a hand-picked selection of promising stocks that InvestingPro has calculated to have serious potential to beat the S&P 500.
Right now we have our sights set on top analyst picks. Not only have Wall Street analysts set their price targets sky high on these companies, but that confidence is bolstered by strong fair value upside as well, per InvestingPro calculations. And these stocks are especially bright because of their excellent Financial Health scores (higher than 2.75) on InvestingPro.
That's a huge sign for investors because InvestingPro analyzes cash flow, profitability, price momentum and more to determine Financial Health. And for the last 7 years, stocks with health scores higher than 2.75 actually outperformed the market.
Take CVS Health (NYSE:CVS) for example. Not only do analysts expect shares of the ubiquitous drugstore chain to soar more than 50% after a sharp retreat from the start of the year, but its InvestingPro fair value predicts an over-40% rise from current levels.
And it’s no wonder: CVS’s 3.14 InvestingPro financial health score means that despite the share drop, you can be confident that the company is on solid footing, particularly when it comes to profitability. With earnings due out shortly, this is a stock to investigate ASAP.
Want to see the full list of this month's Pro Picks poised to beat the market? Start a 7-day free trial to unlock must-have insights and data.
If you're already an InvestingPro subscriber, this week's full Pro Picks list is available here.